Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2025-12-25 @ 2:48 AM
NCT ID:
NCT04024033
Eligibility Criteria:
Inclusion Criteria:
1. Subjects with perennial allergic rhinitis with or without seasonal allergic rhinitis
2. Male or female participants must be 18 years of age or older
Exclusion Criteria:
1. Subjects receiving subcutaneous allergen immunotherapy or monoclonal anti-IgE (omalizumab)
2. Subject with hypersensitivity to PPC
3. Pregnant subjects (lactating post-partum women will be allowed to participate)
4. Subjects who are unable to cooperate/comply with study procedures or communicate with investigator in order to successfully complete the study
5. Subjects with severe skin disorders such as atopic dermatitis, dermatographism, psoriasis who could not have allergy skin testing and who have no prior skin testing completed within 3 years
6. Subjects with an infirmity, disability, or geographical location which seems likely to prevent regular attendance for patient visits
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04024033
Study Brief:
Protocol Section:
NCT04024033